Non-Alcoholic Steatohepatitis (NASH) Trial

Digestive Disease Associates of Rockland and Gen1 Research have partnered in a study evaluating an investigational drug for treatment of liver fibrosis in adult patients who have non-alcoholic steatohepatitis (NASH).  To qualify, participants must:

• Be between the ages if 18 and 75
• Have had liver biopsy or be willing to undergo a liver biopsy

Qualified participants may receive:

• Compensation for time & travel
• Study-related care at no cost

For more information, please contact our Clinical Research Coordinator, Samantha Oberdier, at (845) 367-1621 or soberdier@gen1research.com